title: Acute profound thrombocytopenia after use of eptifibatide for coronary stenting.
abstract: This is a case report of a patient who developed profound thrombocytopenia during treatment with eptifibatide after PCI of the mid right coronary artery.
authors.affiliation: Unité de Cardiologie Interventionelle, Clinique Pasteur, Toulouse, France.
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Salengro
authors.forename: Niall T
authors.initials: NT
authors.lastname: Mulvihill
authors.forename: Bruno
authors.initials: B
authors.lastname: Farah
mesh_terms: D000368:Aged; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects*; D019917:Blood Vessel Prosthesis Implantation / Q000009:adverse effects*; D023921:Coronary Stenosis / Q000188:drug therapy* / Q000601:surgery*; D000077542:Eptifibatide; D006801:Humans; D008297:Male; D010455:Peptides / Q000009:adverse effects* / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D015607:Stents / Q000009:adverse effects*; D013921:Thrombocytopenia / Q000139:chemically induced*
chemical_list: D010455:Peptides; D010975:Platelet Aggregation Inhibitors; D000077542:Eptifibatide